Intravenous Bisphosphonate Therapy may Lead to Osteonecrosis of the Jaw in Multiple Myeloma, Breast, and Prostate Cancer Patients


    loading  Checking for direct PDF access through Ovid

Abstract

ARTICLE TITLE AND BIBLIOGRAPHIC INFORMATIONIncidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapyWang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ.J Oral Maxillofac Surg 2007;65:1328-31STRENGTH OF RECOMMENDATIONCPURPOSE/QUESTIONTo determine the incidence of ONJ in a cohort of patients with multiple myeloma (MM), breast cancer (BC), or prostate cancer (PC) who were receiving intravenous bisphosphonate therapy for an established period of time.SOURCE OF FUNDINGAmerican Association of Oral and Maxillofacial Surgeons Student Training Award; Office of Enrichment Programs, Harvard Medical School; and the Department of Oral and Maxillofacial Education and Research Fund.TYPE OF STUDY/DESIGNRetrospective chart review

    loading  Loading Related Articles